EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award Programme 2022

recision Diabetes Medicine refers to attempts of tailoring diagnosis, prediction, prevention and treatment of diabetes to specific subgroups, and ultimately to the individual. This requires novel approaches by clinical and combined basic + clinical research as well as integration of multidimensional data.



The Programme will accept applications based on scientific quality, innovation potential and a clear translational focus; bringing basic knowledge to use at the patient level in terms of e.g. disease prognosis, treatment prediction or patient stratification.



Applications can be made by any paid-up member of EASD.



Financial support

(number of proposals to be awarded: 3)

- The first ranked proposal will receive up to 2M DKK (≈ €268K).

- The second and third ranked proposals will receive up to 0,5M DKK (≈ €67K).